Latest filing published 11 May 2016 for aTYR PHARMA INC, €6,524.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +13.6%Entry US$40.04 · Close at T+365 US$45.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Grove Matsuoka: trading record in brief
Grove Matsuoka appears in our data through filings on aTYR PHARMA Inc shares, published by SEC (Form 4). Between 9 May 2016 and 11 May 2016, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €33k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 11 May 2016, the filings show an open-market purchase worth €6,524 in aTYR PHARMA Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Grove Matsuoka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,412 shares@ US$3.0819.7% of flowCommon StockSEC:0001209191-16-119377:0Canonical exit: 7 Aug 2016 (T+90)
- 10,000 shares@ US$3.0380.3% of flowCommon StockSEC:0001209191-16-119377:1Canonical exit: 9 Aug 2016 (T+90)
2 of 2 declarations